Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container

   
Google
 
Web NewDrugInformation.com

Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container


Drug - Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Heparin Sodium
Multiple ingredients are in alphabetical order.

Strength - 5,000 UNITS/100ML
The potency of the active ingredient(s), Heparin Sodium. May repeat for multiple part products.

Applicant - B BRAUN
The firm name holding legal responsibility for Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019952
The FDA assigned number to Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 20, 1992
The date Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container is in. Format is RX, OTC, DISCN.

Applicant Full Name - B Braun Medical Inc
The full name of the firm holding legal responsibility for the new application of Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container.

Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container


Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container 10,000 Units/100ml Injectable; Injection
Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container 5,000 Units/100ml Injectable; Injection
Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container 5,000 Units/100ml Injectable; Injection
Heparin Sodium 20,000 Units And Dextrose 5% In Plastic Container 4,000 Units/100ml Injectable; Injection
Heparin Sodium 20,000 Units In Dextrose 5% In Plastic Container 4,000 Units/100ml Injectable; Injection
Heparin Sodium 20,000 Units In Dextrose 5% In Plastic Container 4,000 Units/100ml Injectable; Injection
Heparin Sodium 25,000 Units And Dextrose 5% In Plastic Container 10,000 Units/100ml Injectable; Injection
Heparin Sodium 25,000 Units And Dextrose 5% In Plastic Container 5,000 Units/100ml Injectable; Injection
Heparin Sodium 25,000 Units In Dextrose 5% 10,000 Units/100ml Injectable; Injection
Heparin Sodium 25,000 Units In Dextrose 5% 5,000 Units/100ml Injectable; Injection

NewDrugInformation